D-penicillamine reverses the inhibition of proteoglycan biosynthesis caused by exposure of cultured articular cartilage to hydrogen peroxide.
The sulphydryl containing anti-rheumatic drug D-penicillamine mildly inhibited proteoglycan synthesis in cartilage explant cultures by a mechanism not dependent upon H2O2 generation. More importantly, this drug alleviated the suppression of PG synthesis mediated by 10(-4) M H2O2 in a dose-dependent manner at concentrations of reduced drug similar to those plasma levels reported in vivo. The ability of D-penicillamine to reverse this effect was due solely to a reaction which resulted in scavenging of medium H2O2 and was not due to the "repair" of cellular lesions caused by prior exposure to H2O2.